Cleared Traditional

K011113 - HYDRAGEL ISO-PAL K20 (PN 3022)

Also marketed or referenced as:
HYDRAGEL 7 ISO-PAL (PN 4112) HYDRAGEL 15 ISO-PAL (PN 4132)

K011113 is the FDA 510(k) clearance for HYDRAGEL ISO-PAL K20 (PN 3022) by Sebia. It is a Class 2 Chemistry device (product code CIN) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K011113 · Sebia · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2001
Decision
63d
Days
Class 2
Risk

K011113 is an FDA 510(k) clearance for the HYDRAGEL ISO-PAL K20 (PN 3022). Classified as Electrophoretic Separation, Alkaline Phosphatase Isoenzymes (product code CIN), Class II - Special Controls.

Submitted by Sebia (Chelsea, US). The FDA issued a Cleared decision on June 13, 2001 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1050 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sebia devices

Submission Details

510(k) Number K011113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 2001
Decision Date June 13, 2001
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 88d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes

All 18
Devices cleared under the same product code (CIN) and FDA review panel - the closest regulatory comparables to K011113.
Access Ostase
K232904 · Beckman Coulter · Apr 2024
IDS-iSYS Ostase BAP
K200475 · Immunodiagnostic Systems , Ltd. · Sep 2020
SPIFE 2000/3000 ALP 40, 20
K020625 · Helena Laboratories · May 2002
ACCESS OSTASE IMMUNOENZYMETRIC ASSAY
K994278 · Beckman Coulter, Inc. · Mar 2000
TANDEM-MP OSTASE IMMUNOENZYMETRIC ASSAY
K972666 · Hybritech, Inc. · Sep 1997
OPUS BONE ALP
K964764 · Behring Diagnostics, Inc. · Jan 1997